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Abstract: This report concerns a 12-year-old male with intractable seizures over a long period. The case fulfilled the diagnostic criteria 
for nonherpetic acute limbic encephalitis. He had frequent convulsions starting with a partial seizure at the left angle of the mouth and 
progressing to secondary generalized seizures. He was treated with several anticonvulsants, combined with methylprednisolone and 
γ-globulin under mechanical ventilation. However, his convulsions reappeared after tapering of the barbiturate. His magnetic resonance 
imaging showed a high intensity area in the hippocampus by FLAIR and diffusion. After five months he recovered without serious 
sequelae. Virological studies, including for herpes simplex virus, were all negative. He was transiently positive for antiglutamate recep-
tor antibodies in cerebrospinal fluid and serum.
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Introduction
Nonherpetic  acute  limbic  encephalitis  (NHALE), 
reported as a novel type of acute limbic encephalitis in 
young women where herpes simplex is not detected, 
has  attracted  attention  recently.1 The  cause  of  this 
disease is not identified, but a connection with the 
glutamate receptor antibody has been reported. How-
ever, there are few reports of children with NHALE 
and  antiglutamate  receptor  antibodies.  We  report 
a rare case of a 12-year-old-boy with NHALE who 
was  transiently  positive  for  antiglutamate  receptor 
antibodies  in  cerebrospinal  fluid  and  serum.  This 
is the first report to show the time course of gluta-
mate receptor changes in children with a diagnosis of   
NHALE.
case Report
A  12-year-old  boy  was  admitted  with  convulsions 
to  the  Department  of  Pediatrics  at Tokyo  Medical 
University Hospital. He was born as appropriate-for-
dates by caesarean section because of fetal distress. 
His body weight was 3403 g at 41 weeks. His past 
medical history and family history were unremark-
able. He had one episode of febrile convulsions at the 
age of one year, but otherwise developed normally 
without any serious illness. He had a high fever for 
two days before the episode on July 10, 2004, which 
came down, but he had generalized tonic-clonic sei-
zures lasting for five minutes and was admitted to 
hospital.
On admission, his body temperature was 36.7°C, 
and he was in a stupor (20–30 on the Japan Coma 
Scale). He showed a clustering of seizures with auto-
matic oral movements and unconsciousness and had 
ongoing short-term memory problems. His interic-
tal electroencephalogram, brain magnetic resonance 
imaging, and cerebrospinal fluid parameters were all 
normal. He was diagnosed to have encephalopathy, 
and was treated with anticonvulsants, pulsed steroid 
therapy (three days of methylprednisolone 30 mg/kg), 
and acyclovir.
Because his convulsions were intractable, he was 
moved to our department 10 days after the onset of 
the  illness  in  order  to  achieve  seizure  control.  On 
arrival, his Japan Coma Scale was 100–200. His light 
reflex was prompt, and the deep reflex was decreased. 
White blood cell levels were 14,900/µL and hemo-
globin was 14.1 g/dL. C-reactive protein was high 
at 2.6 mg/dL. Creatine phosphokinase was 547 U/L. 
IgG, IgA, and IgM were 1784 mg/dL, 168 mg/dL, 
and  217  mg/dL,  respectively.  Serum  interleukin-6 
and soluble interleukin-2 receptor were increased to 
38.5 pg/mL (normal 6 pg/mL) and 815 U/mL (nor-
mal  500  U/mL),  respectively.  Cerebrospinal  fluid 
(CSF) showed elevated interleukin-6 at 81.1 pg/mL 
(normal  6  pg/mL)  and  neuron-specific  enolase  at 
56 ng/mL (normal 16.3 ng/mL). Viral studies, includ-
ing polymerase chain reaction for enterovirus, her-
pes simplex virus, and human herpesvirus-6, were 
all negative. Cell count, protein, and CSF pressure 
were all   normal. Metabolic studies (amino acid, mus-
cle biopsy, fatty acid, lactic acid, pyruvic acid) were 
normal. Magnetic resonance imaging showed a high 
density area in the hippocampus by FLAIR and dif-
fusion on day 21 (Fig. 1). Because he had clustered 
convulsions, comprising partial seizures starting at 
the left angle of the mouth with unconsciousness and 
generalized seizures, he was treated under mechani-
cal ventilation. Depressants for cerebrospinal pres-
sure and anticonvulsants (barbiturate, phenobarbital, 
midazolam, clonazepam, carbamazepine, phenytoin) 
were used. A combination of pulsed methylpredniso-
lone therapy for three days and high-dose γ-globulin 
was also used. Despite this therapy, his convulsions 
reappeared after tapering the barbiturates over five 
months. On day 173 after admission, his convulsions 
were finally controlled with clonazepam and valproic 
acid, and discontinuation of mechanical ventilation 
and barbiturates was possible (Fig. 2). He showed 
mild gait disturbances because of contractures of the 
foot joints during his prolonged bed rest, but did not 
show any mental retardation (language 105, physi-
cal 89, total 97, on Wechsler Intelligence Scale for 
  Children III).
The patient was discharged after 258 days. His 
brain images showed neither atrophy nor enlargement 
of the ventricles. For two years he had no convulsions. 
Antiglutamate  receptor  antibodies  were  detected 
transiently in serum and cerebrospinal fluid after one 
month, as shown in Table 1. Although cerebrospinal 
fluid findings suggested viral infection, a virological 
study could not demonstrate infection attributable to 
herpes simplex virus type 1 or type 2, varicella zoster 
virus, cytomegalovirus, measles virus, mumps virus, 
Japanese encephalitis virus, or influenza virus type A 
and B in serum.Acute limbic encephalitis
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Aug 30, 2004 FLAIR
on 21st day after admission
TR 9000.0
TE 137.0
Aug 30, 2004 diffusion
on 21st day after admission
TR 5100.0
TE 178.0
Figure 1. MRI imaging on 21st day after the onset. Bilateral hippocampus show high intensity area (right dominant) was visible.
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Figure 2. The general cause (y axis mean numbers of seizure per day) of the patient.
Discussion
This  patient  showed  memory  disturbance, 
  unconsciousness, and clustering of seizures with oral 
automatisms  requiring  administration  of  multiple 
anticonvulsant  medications,  high-dose  γ-globulin, 
pulsed  steroid  therapy,  and  thiopental.  He  did  not 
present  with  febrile  episodes  during  the  period 
of  seizure-  clustering,  interictal  electroencephalo-
graphic abnormalities throughout the clinical course, 
or intellectual impairment as sequelae. As such, his Kawashima et al
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  clinical   symptoms and magnetic resonance images 
are  c  onsistent  with  NHALE.  Glutamate  receptor 
antibody was detected in blood and spinal fluid. It 
has been reported that this antibody is often posi-
tive  in  Rasmussen  syndrome,  acute  encephalitis/
encephalopathy,2 and acute encephalitis with refrac-
tory repetitive partial seizures (AERRPS).3–6
Rasmussen’s  syndrome,  which  occurs  in  child-
hood, presents with intractable partial motor seizures 
and  slowly  progressive  neurological  deterioration, 
hemiplegia, and intellectual impairment. Pathologi-
cal studies demonstrate that this syndrome involves 
one hemisphere of the brain.7 Therefore, the clinical 
symptoms of the present case are not consistent with 
any of those disorders. From many studies of this 
syndrome, the antibody to the glutamate receptor has 
been thought to be a possible mechanism in which 
the antibody might directly trigger seizures by over-
stimulation of the glutamate receptor.
In our case, the symptomatic zone was suspected 
to be the hippocampus with secondary radiation to 
the opercular region. His initial symptoms were simi-
lar to those of postencephalitic epilepsy which affects 
these regions first, but these cases usually have easily 
controlled seizures in the acute phase. In contrast, the 
seizures continued for about 170 days in our patient, 
and he recovered without any serious sequelae. There-
fore, the clinical symptoms do not support a diagnosis 
of postencephalitic epilepsy.
The most important disorder to be considered for 
a differential diagnosis is AERRPS. The diagnostic 
  criteria6 include three mandatory items, ie, acute onset 
of seizures or impairment of consciousness without 
underlying neurological abnormalities, extraordinary 
frequent, refractory partial seizures, and continuous 
switchover  to  refractory  epilepsy  without  a  latent 
period,  and  supporting  findings  of  an  antecedent 
febrile illness, persistent fever during acute phase, 
mild cerebrospinal fluid pleocytosis or upregulation 
of  inflammatory  markers,  electroencephalographic 
abnormalities, nonspecific magnetic resonance imag-
ing abnormalities, and profound neurologic sequelae. 
The present case did not meet the third criterion for 
AERRPS.
On  the  other  hand,  the  symptoms  and  images 
were  very  similar  to  those  of  NHALE.  Childhood 
NHALE  has  been  reported  recently,8,9  but  remains 
rare. NHALE is regarded as a new subtype of lim-
bic encephalitis. Asaoka et al investigated six patients 
with NHALE and compared them with cases of her-
pes simplex virus encephalitis. The NHALE patients 
demonstrated both acute limbic encephalitis and mag-
netic resonance imaging abnormalities in the bilateral 
hippocampus and amygdala. However, interleukin-6 
and  IFN-γ  levels  in  cerebrospinal  fluid  from  the 
patients with NHALE were significantly lower than 
in that from patients with herpes simplex encephalitis. 
Asaoka et al argued that an immunological process in 
this type of NHALE could be a possible source, rather 
than a direct viral infection.10
Autoantibodies to glutamate receptor ε2 were also 
reported by Hayashi et al in adult cases of NHALE.1 
In our patient, we detected IgM type autoantibodies 
to glutamate receptor δ2 and ε2 in both the cerebro-
spinal  fluid  and  serum,  and  these  antibodies  nor-
malized in the cerebrospinal fluid over the clinical 
course of the illness. Antiglutamate receptor ε anti-
body in cerebrospinal fluid is known to correlate with 
mental retardation and late appearance of epilepsy. 
Antiglutamate receptor antibodies are also known to 
be detected in the serum and cerebrospinal fluid of 
patients with chronic progressive   epilepsia partialis 
Table 1. Anti-glutamate receptor antibodies in the patient which were assayed by the method of Takahashi.2
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Cerebrospinal fluid IgG epsilon-2
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–
–
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+
–
–
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–
–
–
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–
+
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continua  of  childhood,  patients  with    Rasmussen’s 
encephalitis,11 and those with AERRPS. Moreover, it 
has been reported that encephalitis and encephalopa-
thy without any deterioration may also show positive 
for these antibodies.11,12 Recently, novel clinical syn-
dromes, such as NHALE and AERRPS, which are 
suggested to be based on autoimmune mechanism, 
have been recognized as distinct clinical entities. The 
present case was diagnosed as NHALE, but shares 
some characteristics with AERRPS. More studies on 
autoimmune etiology are necessary. This 12-year-old 
boy with nonherpetic acute limbic encephalitis and 
transiently positive for antiglutamate receptor anti-
bodies in cerebrospinal fluid and serum recovered 
after five months without serious sequelae.
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